Product Information
VARENICLINE STARTING MONTH BOX is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.4122 per EA under NDC 68462089504. Its NADAC has been published 148 times since Oct 25, 2023.
FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the varenicline tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462089504
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA214255FDA Approved
8/1/2023
TE Code
AB
On Market Since
8/22/2023
Price Statistics
The NADAC for VARENICLINE STARTING MONTH BOX has been published 148 times since Oct 25, 2023, and over the history we have for it it has declined 93.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4122 per EA |
|---|---|
| All-time high | $6.5609 (Nov 15, 2023) |
| All-time low | $0.4066 (Nov 20, 2024) |
| 52-week high | $0.5229 |
| 52-week low | $0.4122 |
| Median price | $0.6196 |
| Average price | $1.4933 |
| Largest weekly change | +71.9% (Dec 18, 2024) |
| Weeks tracked | 148 |
| Tracking since | Oct 25, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VARENICLINE STARTING MONTH BOX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE STARTING MONTH BOX, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.4122 per EA (NDC 68462089504), effective Aug 19, 2026.
How has the price of VARENICLINE STARTING MONTH BOX changed over time?
Over the history we have for it, the NADAC for VARENICLINE STARTING MONTH BOX has declined 93.7%. It has been tracked across 148 weekly CMS publications since Oct 25, 2023.
What are the highest and lowest recorded NADAC prices for VARENICLINE STARTING MONTH BOX?
Since Oct 25, 2023, the NADAC for VARENICLINE STARTING MONTH BOX has ranged from a low of $0.4066 (Nov 20, 2024) to a high of $6.5609 (Nov 15, 2023), with a median of $0.6196 per EA.
Are there cheaper alternatives to VARENICLINE STARTING MONTH BOX?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VARENICLINE STARTING MONTH BOX in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE STARTING MONTH BOX?
VARENICLINE STARTING MONTH BOX (NDC 68462089504) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.